Cara Therapeutics (NASDAQ: CARA)
| Last Price | $26.42 |
| Net Change | $1.01 (3.97%) |
| Bid | $0 |
| Ask Price | $0 |
| Open Price | $26.87 |
| Previous Close Price | $25.41 |
| High Price | $28.5 |
| Low Price | $25.7 |
| Number of Trades | 25,648 |
| Volume | 7,980,034 |
| Fifty Two Week High | $28.5 (2017-06-27) |
| Fifty Two Week Low | $4.6 (2016-06-28) |
| Average Daily Volume | 2,032,926 |
| Share Outstanding | 32,510 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $-0.81 (2017-05-04) |
| 2nd Quarter Earnings | $-0.81 (2017-03-09) |
| 3nd Quarter Earnings | $-0.42 (2016-11-03) |
| 4th Quarter Earnings | $-0.48 (2016-08-04) |
| PE Ratio | $0 |
| EPS Growth | $-20.71 |
| Recent Earnings | $-0.81 |
| Annual EPS | $-2.52 |
| Last Quarter EPS | $ |
| Market Capitalization | $0.74B |
| Insider Shareholders % | 0.075% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 32,510 |
| Inst. Shareholder % | 52.91% |
| Annual Net Income | $-0.07B |
| TTM Net Profit Margin | $-6948.48 |
| 1-Year Return | 367.98% |
| 3-Year Return | 38.45% |
| 5-Year Return | 75.45% |
| 5-Year Revenue Growth | 0% |
| 5-Year Earnings Growth | 0% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | -20.709999% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 3.16 |
CARA News & Stock Updates
June 9, 2017
Top Medical Marijuana Stocks to Watch TodayMarch 28, 2017
Top Stocks to Watch Today: TSLA, DRYS, CARAMarch 24, 2017
The 5 Best Medical Marijuana Stocks to Watch in 2017November 15, 2016
Why the Top Medical Marijuana Stocks Are ClimbingNovember 9, 2016
Marijuana Stocks to Watch After 7 States Legalize